D. Gershenson
Nature Medicine · 2004–2021
A researcher in the Science corpus: 4 papers; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Who trusts D. Gershenson
- J. Prat (in Reproductive Medicine)
Papers from D. Gershenson's perspective
Ordered by how strongly the researchers D. Gershenson trusts endorse each paper. Same corpus, a different order for every researcher.
- Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. (Cancer Research)
- The Statistical Analysis of Failure Time Data (Technometrics)
- Nonparametric Estimation from Incomplete Observations
- Stress-induced immune dysfunction: implications for health (Nature reviews. Immunology)
- Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. (Journal of Clinical Oncology)
Their papers
- Grading Ovarian Serous Carcinoma Using a Two-Tier System (2004) — 674 citations
- Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. (2021) — 597 citations
- Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma (2006) — 1,286 citations
- Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. (2004) — 1,011 citations